- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in clinical trials
Exploring India's Increasing Role in Clinical Trials, Addressing Key Concerns
The key drivers for clinical trials in India include access to treatment-naïve patients (especially in Tier 2 and 3 cities), a high disease burden, lower cost, and good medical infrastructure (even in Tier 2/3 cities)
Read MoreParexel Declares India As A Burgeoning Centre For Clinical Trials
Previously, if companies wanted to conduct trials in 28 countries, India would typically be ranked 20th. However, India now features among the top 5-10 countries for such trials
Read MoreCentre Says Reports In Media Of Hasty Approvals For Bharat Biotech's Covaxin Are Misleading
Centre on Thursday said that media reports claiming that Bharat Biotech, manufacturer of the indigenous COVID-19 vaccine Covaxin, “had to skip certain processes” and “speed” up clinical trials due to political pressure are completely misleading, fallacious and ill-informed
Read MoreFDA Will Not Need Clinical Trial Data To Authorise Modified Covid Boosters Says Official
The FDA on Thursday recommended COVID-19 vaccine manufacturers change the design of their booster shots beginning this fall to include components tailored to combat the currently dominant Omicron BA.4 and BA.5 subvariants of the coronavirus
Read MoreCovaxin's Clinical Trials Can Resume In US As FDA Lifts Hold
The FDA's earlier decision, in April, to put on hold the trials was based on the US firm's decision to voluntarily implement a temporary pause in dosing participants of the jab, following the World Health Organisation's observations on Covaxin manufacturing plants in India
Read MoreRML Resident Doctors' Association opposes Bharat Biotech's Covaxin vaccine, cites 'lack of complete trial'
RML Resident Doctors' Association opposes Bharat Biotech's Covaxin vaccine, cites 'lack of complete trial'
Read MoreCOVID-19: Bharat Biotech enrols 25,800 volunteers for Covaxin phase-3 clinical trials
COVID-19: Bharat Biotech enrols 25,800 volunteers for Covaxin phase-3 clinical trials
Read MorePeru authorizes resumption of clinical trials of Sinopharm vaccine
Peru authorizes resumption of clinical trials of Sinopharm vaccine
Read MoreRussian envoy says cooperation in countering COVID-19 priority area of bilateral partnership
Russian envoy says cooperation in countering COVID-19 priority area of bilateral partnership
Read MoreDr Harsh Vardhan launches CuRED, CSIR partnered clinical trials website
Dr Harsh Vardhan launches CuRED, CSIR partnered clinical trials website
Read MoreDr Reddy's, RDIF to supply 100 million doses of Sputnik V vaccine to India
Dr Reddy's, RDIF to supply 100 million doses of Sputnik V vaccine to India
Read MoreDGCI directs Serum Institute to suspend any new recruitment in phase 2, 3 COVID-19 vaccine clinical trials
DGCI directs Serum Institute to suspend any new recruitment in phase 2, 3 COVID-19 vaccine clinical trials
Read MoreCSM Technologies launches CoVID-19 vaccine tracker as the world eagerly awaits a panacea for the pandemic
CSM Technologies launches CoVID-19 vaccine tracker as the world eagerly awaits a panacea for the pandemic
Read MoreCurrent claims over Covishield false, vaccine to be commercialised only after trials prove successful: SII
Current claims over Covishield false, vaccine to be commercialised only after trials prove successful: SII
Read MoreAt Rs 2,800, Zydus Launches Remdac For Treatment Of COVID-19 In India
Managing Director Sharvil Patel said Remdac is the most affordable drug as the company would like to enable patients to have access to this critical drug in the treatment of COVID-19.
Read More